Fulcrum therapeutics presents published structure of investigational small molecule ftx-6058 at the american chemical society (acs) spring 2021 virtual conference

Company initiates dosing in phase 1 healthy volunteer multiple ascending dose (mad) cohort company initiates dosing in phase 1 healthy volunteer multiple ascending dose (mad) cohort

FULC Ratings Summary

FULC Quant Ranking